Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3251115

Beta release

Statistics of Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Statistics for this year
PeriodVisitsDownloads
20241817
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0922
2024-1022
2024-1111